Ignite Creation Date:
2024-05-06 @ 4:09 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04897477
Status:
UNKNOWN
Last Update Posted:
2021-05-21
First Post:
2021-05-18
Brief Title:
Azacytidine Bendamustine Piamprizumab in RefractoryRelapsed B-cell Non-Hodgkins Lymphoma
Sponsor:
Organization:
Chinese PLA General Hospital